Surgery Partners stock (US85701Q1031): earnings update and growth plans put outpatient operator in focus

Surgery Partners has reported fresh quarterly figures and updated its outlook, keeping the fast-growing outpatient surgery operator on the radar of US healthcare investors. What is behind the latest numbers and how does the business model generate revenue?

Surgery Partners has recently published new quarterly results and discussed its growth strategy, keeping the stock in focus among US healthcare investors. For the first quarter of 2026, the company reported higher revenue and continued volume growth in its ambulatory surgery centers and surgical hospitals, according to a results release dated early May 2026 on its investor relations website, as referenced by Surgery Partners IR as of 05/2026. The company also commented on its full-year outlook for 2026, underlining expectations for further expansion in same-facility case volumes and revenue mix.

In the same update, management highlighted ongoing demand in musculoskeletal procedures and gastrointestinal treatments, which remain key drivers of case growth and revenue for Surgery Partners locations, according to Surgery Partners website as of 05/2026. The company mentioned that it continues to pursue tuck-in acquisitions and partnerships with physician groups, while also focusing on cost discipline in labor and supplies. These aspects featured prominently in the recent discussion of margins and profitability trends.

As of: 17.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: SGRY
• Sector/industry: Healthcare services, outpatient surgery centers
• Headquarters/country: United States
• Core markets: Ambulatory surgery centers and surgical hospitals in the US
• Key revenue drivers: Surgical case volume, payer mix, reimbursement rates
• Home exchange/listing venue: Nasdaq (ticker: SGRY)
• Trading currency: USD

Surgery Partners: core business model

Surgery Partners operates a network of ambulatory surgery centers and surgical hospitals across the United States, focusing on procedures that can be performed outside traditional inpatient hospital settings. The company works with physicians, payers and patients to provide surgical services in orthopedics, pain management, gastroenterology and other specialties, according to Surgery Partners website as of 03/2026. Its facilities are typically designed to offer efficient throughput and standardized care pathways.

The business model is built around partnering with physicians who often hold equity stakes in individual centers, aligning incentives on case volumes and quality metrics. Surgery Partners generates revenue primarily from facility fees paid by commercial insurers, government programs and patients for procedures performed in its centers, as described in its latest annual report filed in early 2025 for the 2024 fiscal year, according to Surgery Partners IR as of 03/2025. The company also provides ancillary services such as anesthesia through affiliated practices in some locations.

Because most of its facilities are focused on same-day or short-stay procedures, the company seeks to benefit from the shift of surgical care from inpatient hospitals to outpatient settings. This shift is driven by advances in minimally invasive techniques, payer cost-containment efforts and patient preference for convenient care. Surgery Partners positions itself as a lower-cost alternative to hospital outpatient departments for many elective procedures, and its centers sometimes compete directly with hospital-owned facilities in local markets, according to commentary in prior investor presentations referenced by Surgery Partners IR as of 09/2025.

The company’s model also involves actively managing capacity, scheduling and staff mix to maintain high utilization rates. Management has repeatedly emphasized operational efficiency, including optimization of operating room time and standardization of clinical and administrative workflows, as a key margin lever, according to comments during previous earnings calls summarized by Nasdaq as of 11/2025. This operational focus is particularly important in an environment of rising labor and supply costs.

Main revenue and product drivers for Surgery Partners

An important revenue driver for Surgery Partners is case volume growth in targeted specialties such as orthopedics, spine and cardiology-related procedures that continue to migrate into outpatient settings. The company has highlighted musculoskeletal procedures as a focus area, describing strong demand in total joint replacements and spine surgeries performed in ambulatory centers, according to its first quarter 2026 earnings commentary published in May 2026, as referenced by Surgery Partners IR as of 05/2026. Higher case complexity per visit can support revenue per case, but also requires investment in equipment and specialized staff.

Payer mix and reimbursement trends form another structural revenue driver. Surgery Partners’ centers receive payments from commercial insurance plans, Medicare, Medicaid and self-pay patients. Shifts towards commercial and Medicare Advantage coverage can influence average reimbursement rates and margins. In its 2024 annual report, filed in early 2025, the company pointed out that commercial payers remain a significant contributor to profitability while public payers provide important volume, according to SEC filing as of 03/2025. Changes in Medicare reimbursement policies for ambulatory surgery centers can create both headwinds and tailwinds over time.

Acquisitions of new centers and strategic partnerships with physician groups are a further growth engine. Surgery Partners has a track record of acquiring additional facilities and entering joint ventures with health systems to expand its footprint. While specific transaction details differ from deal to deal, management has indicated that disciplined capital deployment remains a priority and that acquired centers are expected to contribute to adjusted EBITDA over time, according to management statements during a capital markets presentation in late 2025, referenced by Surgery Partners IR as of 12/2025. Integration and alignment with local physician partners are seen as keys to realizing synergies from such deals.

Cost management is also central to the revenue equation because it affects profitability on each case. Labor costs, including nurses, surgical technologists and administrative staff, have been under pressure across the US healthcare system since the pandemic. Surgery Partners has described initiatives to optimize staffing levels and use flexible labor models to balance quality of care with cost efficiency, according to its fourth quarter 2025 results release dated February 2026, as cited by Reuters as of 02/2026. Supply chain management for implants and medical devices, often purchased from large manufacturers, is another area where the company seeks volume-based discounts.

Conclusion

Surgery Partners combines a network-based business model in outpatient surgery with exposure to long-term trends such as the migration of procedures out of hospitals. The latest quarterly results for the first quarter of 2026, released in early May 2026, underline continued revenue growth and an ongoing focus on cost discipline and acquisition-led expansion, according to Surgery Partners IR as of 05/2026. For US investors, the stock offers a way to gain targeted exposure to ambulatory surgical services, but the business remains sensitive to payer policies, labor costs and integration execution in a competitive healthcare market.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.